Related Experiment Video
Updated: Jun 25, 2026

06:19
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
3.9K
An Entropy Approach to Multiple Sclerosis Identification.
Gerardo Alfonso Perez1, Javier Caballero Villarraso1,2
1Department of Biochemistry and Molecular Biology, University of Cordoba, 14071 Cordoba, Spain.
Journal of Personalized Medicine
|March 25, 2022
Summary
A new method using DNA methylation (cytosine-phosphate-guanine) and Shannon Entropy improves multiple sclerosis diagnosis. This technique accurately identifies MS by selecting key DNA markers, outperforming existing methods.
Area of Science:
- Neuroscience
- Genetics
- Bioinformatics
Background:
- Multiple sclerosis (MS) is a common neurodegenerative disease with variable progression, making clinical diagnosis challenging.
- The exact causes of MS are unknown but likely involve genetic and environmental factors.
- Current diagnostic methods can be difficult due to the unpredictable nature of MS symptom onset and remission.
Purpose of the Study:
- To develop a novel, cost-effective tool for identifying multiple sclerosis (MS).
- To utilize DNA CpG methylation patterns for improved MS classification.
- To enhance diagnostic accuracy by selecting informative genetic markers.
Main Methods:
- A technique based on Shannon Entropy was developed to select relevant DNA CpG sites.
- CpG sites were used as inputs for non-linear classification algorithms.
- Patient data was analyzed controlling for age, gender, and smoking status.
Main Results:
- The proposed method achieved accurate classifications of MS.
- This approach demonstrated statistically significant improvements over using all available data or random CpG selection.
- The number of CpGs required for classification was reduced while accuracy was increased.
Conclusions:
- DNA CpG methylation analysis, guided by Shannon Entropy, offers a promising tool for MS diagnosis.
- This method provides a more accurate and efficient approach to identifying MS compared to traditional strategies.
- The findings suggest a potential for a quicker, less expensive diagnostic aid for multiple sclerosis.

